Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of ARQ 501 in Squamous Cell Carcinoma of the Head and Neck
2006-001942-15Phase 2Completed
- Sponsor
- ArQule
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lapachone in head and neck squamous cell carcinoma (HNSCC) and squamous cell carcinoma (SCC), sponsored by ArQule. Primary endpoint: Overall Response Rate. Started Aug 2006; status: completed.
02
Drugs
lapachone
03
Conditions
head and neck squamous cell carcinoma (HNSCC)squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on 2006-001942-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001942-15.